Using gene expression profiles from ovarian cancer tumor samples provided by Jazaeri et al. 52, we first calculated sample-specific BRCA scores for each patient in the dataset using the BRCA1/2-based breast cancer profile. This evidence concerns the gene BRCA1 and breast carcinoma.